Viatris was formed in 2020 through the combination of Mylan and Upjohn. By integrating the strengths of these two companies, including our global workforce of ~38,000, we aim to deliver increased access to affordable, quality medicines for patients worldwide. We are a company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. Because health matters everywhere. Our global portfolio includes best-in-class, iconic brand name products as well as global key brands; generics, including branded and complex generics, across a wide range of therapeutic areas. We are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.